A short introduction on

Slides:



Advertisements
Similar presentations
Katrina Abuabara, MD, MA1 Esther E Freeman MD, PhD2;
Advertisements

The golden standard or fools gold Selective data, impact on safety Clinical trials on trial HAI Europe Open Seminar 2008 Neues Stadthaus, Berlin, 21 November.
Evidence-based approach to imaging-based thrombolysis beyond the 4
Centre for Evidence-Based Medicine
Πόσο σίγουροι είμαστε για το όφελος της ενδαρτηρεκτομής; Γεώργιος Ντάιος Παθολογική Κλινική & Ομώνυμο Ερευνητικό Εργαστήριο Ιατρική Σχολή Πανεπιστημίου.
PubMed was searched for randomized clinical trials published between 2007 and 2012 in the New England Journal of Medicine (NEJM) Trials were included if.
Holger Schünemann, MD, PhD From Evidence to EMS Practice: Building the National Model Washington, September 4,
Monitoring: What, when and how long? George Ntaios University of Thessaly, Larissa, Greece.
The Science of Guidelines The 7th ACCP Conference on Antithrombotic and Thrombolytic Therapy: Evidence-Based Guidelines Holger Schünemann, MD, PhD Italian.
Chicago 2014 Peter Morley, Eddy Lang E3, GRADE expert Incorporating lower levels of evidence.
Critically Evaluating the Evidence: Tools for Appraisal Elizabeth A. Crabtree, MPH, PhD (c) Director of Evidence-Based Practice, Quality Management Assistant.
Summarising findings about the likely impacts of options Judgements about the quality of evidence Preparing summary of findings tables Plain language summaries.
Estimation and Reporting of Heterogeneity of Treatment Effects in Observational Comparative Effectiveness Research Prepared for: Agency for Healthcare.
Grading of Recommendations Assessment, Development and Evaluation (GRADE) Methodology.
Κρυπτογενή εγκεφαλικά έμφρακτα:
Κρυπτογενές ισχαιμικό έμφρακτο Γεώργιος Ντάιος Επίκουρος Καθηγητής Παθολογίας, Πανεπιστήμιο Θεσσαλίας 3 ο Συνέδριο ΙΜΕΘΑ Αθήνα, 24/4/2014.
Dallas 2015 TFQO: Karen Woolfrey COI #261 EVREV 1: Karen Woolfrey COI #261 EVREV 2: Daniel Pichel COI #513 Taskforce: ACS ACS 873: Pre-hospital STEMI Activation.
Illustrating the GRADE Methodology: The Cather Associated-UTI Case Study TEACH Level II Workshop 5 NYAM August 9 th, 2013 Craig A Umscheid, MD, MSCE, FACP.
Using GRADEpro to create Evidence Profiles and Summary of Findings Tables Wednesday 19 January to 1330 (PT) Nancy Santesso McMaster University.
Society of General International Medicine 32 nd Annual Meeting, May 14 th 2009 Elie A. Akl, MD, MPH, PhD David Atkins, MD, MPH Eric Bass, MD, MPH Yngve.
University of Thessaly, Larissa, Greece
Brief summary of the GRADE framework Holger Schünemann, MD, PhD Chair and Professor, Department of Clinical Epidemiology & Biostatistics Professor of Medicine.
Japan Endovascular Treatment Conference 2014 JET2014 Digital Poster.
A 2-hour Accelerated Diagnostic Protocol to Assess Patients With Chest Pain Symptoms Using Contemporary Troponins as the Only Bbiomarker (ADAPT) Martin.
Plan GRADE backgroundGRADE background confidence in estimates (quality of evidence)confidence in estimates (quality of evidence) evidence profilesevidence.
Chicago 2014 TFQO: Nikolaos Nikolaou COI#253 EVREV 1: Nikolaos Nikolaou COI#253 EVREV 2: Farzin BeyguiCOI#202 Taskforce: ACS STEMI transfer PCI vs. FL.
American College of Chest Physicians (ACCP) Health and Science Policy Committee Orientation Program Part #4 Grading and Wording of Recommendations.
Standards for Systematic Reviews of Clinical Effectiveness Research Standards for Systematic Reviews of Clinical Effectiveness Research Institute of Medicine.
University of Thessaly, Larissa, Greece
Objectives  Identify the key elements of a good randomised controlled study  To clarify the process of meta analysis and developing a systematic review.
WHO GUIDANCE FOR THE DEVELOPMENT OF EVIDENCE-BASED VACCINE RELATED RECOMMENDATIONS August 2011.
A-1 Introduction Pravastatin-Aspirin 7asdf Fred T. Fiedorek, M.D. Vice President, Clinical Design & Evaluation, Metabolics Pharmaceutical Research Institute.
Japan Endovascular Treatment Conference 2015 JET2015 General Presentation.
Dallas 2015 TFQO: Allan de Caen COI #38 EVREV 1: Tia Raymond COI #153; EVREV 2: Jonathan Egan COI #44 Taskforce: Peds The role of invasive vascular monitoring.
Japan Endovascular Treatment Conference 2014 JET2014 コメディカルセッション.
Dallas 2015 TFQO: Vinay Nadkarni #375 EVREV 1: Vinay Nadkarni #375 EVREV 1: Dave Kloeck #126 Taskforce: Paeds Paed 424: Vasopressors in Paediatric cardiac.
Stroke in the era of NOACs George Ntaios MD, MSc (Stroke Medicine), PhD University of Thessaly, Greece Oslo 11/12/2015.
Κρυπτογενή εγκεφαλικά έμφρακτα Γεώργιος Ντάιος Παθολογική Κλινική, Πανεπιστήμιο Θεσσαλίας.
Trusted evidence. Informed decisions. Better health. Audit of planned methods for using GRADE and preparing SoF tables in protocols of systematic reviews.
GDG Meeting Wednesday November 9, :30 – 11:30 am.
Japan Endovascular Treatment Conference 2016 JET2016 General Presentation.
Dallas 2015 TFQO: Robert Greif EVREVs: Dana Edelson, COI #334 Robert Greif, COI #344 Taskforce: EIT EIT 645: Debriefing of resuscitation performance.
Dallas 2015 TFQO: Name EVREVs: Names and #COI Taskforce: Name Insert Short PICO title Total of 12 (no studies) to 20 slides (maximum) using standard format.
Considerations in grading a recommendation methodological quality of evidencemethodological quality of evidence likelihood of biaslikelihood of bias trade-off.
GRADE Grading of Recommendations Assessment, Development and Evaluation British Association of Dermatologists April 2014.
Clinical Practice Guidelines: Can we fix Babel? Eddy Lang Department Chair, Emergency Alberta Health Services Associate Professor University of Calgary.
Webinar May 25th METHYLPHENIDATE FOR CHILDREN AND ADOLESCENTS WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)
Embolic Strokes of Undetermined Source
Γεώργιος Ντάιος Παθολογική Κλινική, Πανεπιστήμιο Θεσσαλίας Διαχείριση αντιπηκτικής αγωγής εν όψει προγραμματισμένων επεμβατικών πράξεων.
From evidence to Policy: Paediatric guideline development in Kenya Mercy Mulaku.
Γεώργιος Ντάιος Παθολογική Κλινική Πανεπιστημίου Θεσσαλίας Κλινικές περιπτώσεις με μη βαλβιδική κολπική μαρμαρυγή.
Peter Wyer MD Associate Professor of Medicine
Why this talk? you will be seeing a lot of GRADE
Difficult situations in anticoagulation after stroke
Conflicts of interest Major role in development of GRADE
Systematic Review Systematic review
Supplementary Table 1. PRISMA checklist
Overview of the GRADE approach – selected slides
for patients with dyslipidemia & previous stroke/TIA
The EUROMAX trial is supported by The Medicines Company
Alfred A. Bartolucci, PhD, Michal Tendera, MD, George Howard, DrPH 
Part I Who should disclose at my CME event?
WHO Guideline development
Summary of Findings tables in Cochrane reviews
Effects of Combination Lipid Therapy on Cardiovascular Events in Type 2 Diabetes Mellitus: The Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Giuseppe Biondi Zoccai University of Turin, Turin, Italy
on Behalf of the COGENT Investigators
Supervised walking therapy in patients with intermittent claudication
Financial Disclosure Financial Interest / Affiliation
Presentation transcript:

A short introduction on European Stroke Conference / Stroke Guidelines A short introduction on George Ntaios MD, MSc (ESO Stroke Medicine), PhD, FESO University of Thessaly, Larissa, Greece Nice 08/05/2014

Honoraria: Medtronic; Quintiles. Disclosures Scholarships: European Stroke Organization; Hellenic Society of Atherosclerosis. Honoraria: Medtronic; Quintiles. Speaker fees: Sanofi; Boehringer-Ingelheim. Consultant fees: Boehringer-Ingelheim. Support to attend conferences: Bayer; Sanofi-Aventis; Pfizer; Lundbeck; Boehringer-Ingelheim; Galenica; Elpen; Bristol Myers Squibb. Participation in trials: ENOS / National co-ordinator (Greece). BPREVISE / Principal investigator. FOURIER / Sub-investigator. GLORIA / Sub-investigator.

Grading of Recommendations, Assessment, Development and Evaluation GRADE Grading of Recommendations, Assessment, Development and Evaluation Thank you Mr chairman. Dear colleagues, in the next couple of minutes, we will make a short introduction to the GRADE system. The GRADE approach is a method of grading the quality of evidence and strength of recommendations in health. It stands for …… , and it is used to develop clinical practice guidelines and other health care recommendations.

And these are a few organizations that have endorsed the GRADE system.

Population Intervention Comparator Outcome* Specify the PICO question(s) Population In children during summertime Intervention chocolate ice-cream Comparator studying mathematics Outcome* happiness Now, we will try to give a brief view on the methodology which is followed according to GRADE. First, you need to define your PICO questions, and PICO stands for ….. . So, as a non-medical example, your PICO question could be the following one:…. So, now we have to answer this question, although I think we don’t need a randomized controlled trial to answer this one.

Observational studies start low Assessment of quality of studies After you have defined your PICO question, you have to search the literature for related data. And you need to make a broad search including all available databases, not only Medline. Now, it’s up to you whether you will include only randomized controlled trials or also non-randomized data. Then, as soon as you are finished with the literature search, you have to assess the quality of these data. If you include only RCTs, then you start high. If you include also observational studies, then you start low. RCTs start high Observational studies start low

Assessment of quality of studies (downgrade) Study design and execution (bias) Inconsistency (heterogeneity, I2) Indirectness Imprecision (number of events, confidence intervals) Publication bias (funnel plot) Then, you have to assess several parameters which will either downgrade or upgrade the quality of the data. Such parameters which may downgrade the quality of the studies include ….

Large magnitude of the effect Dose – response relation Assessment of quality of studies (upgrade) Large magnitude of the effect Dose – response relation On the other hand, the quality of the included studies may be upgraded if the magnitude of the estimated effect is large, and if there is a dose-response relation.

Grade of evidence Then, you come to grade your evidence, which may be high, meaning that …., moderate meaning that …, low meaning that … or very low meaning that ….

Summary of Findings (SoF) tables And then, you can generate this kind of tables, which are called summary of findings tables, which contain all necessary information. Of course, they may seem complicated but they are a great summary including all important information like the outcomes assessed, number of participants and studies included, the grading of evidence, and others.

Panel discussion Overview Finally, your committee needs to discuss and finalize its recommendation. So, this is an overview of the whole process, as we summarized it. Of course, if you are lucky and your PICO question is very simple like the ice-cream question of our example, then you could just skip all this work and you just have a look at your child and you get a straightworward reliabe answer! Thank you!